Qu Biologics
Business Services · Canada · 11-50 Employees
View Company Info for Free
Overview
Headquarters
4475 Wayburne Dr Suite 305, Burnaby, Bri...Phone Number
(604) 734-1450Website
www.qubiologics.comRevenue
<$5 MillionIndustry
About Qu Biologics
Qu Biologics is at the forefront of developing Site Specific Immunomodulators (SSIs), a novel immunotherapy platform aimed at restoring normal immune function to combat cancer, chronic inflammatory diseases, and metabolic disorders. Their innovative approach leverages the body's natural immune response, targeting specific organs to address immune dysfunction associated with various diseases. Currently, Qu Biologics is conducting a Phase 2 clinical trial to evaluate the efficacy of their QBECO SSI in preventing post-operative immune suppression in late-stage colon cancer patients. The company is committed to transforming treatment paradigms and advancing the potential of SSIs across multiple health conditions.Explore more
Qu Biologics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to Qu Biologics
Compare insights from companies similar to Qu Biologics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Qu Biologics Tech Stack
A closer look at the technologies used by Qu Biologics
Top Business Services Companies
Top companies in New Zealand by revenue
Top companies in United Kingdom by revenue
Frequently Asked Questions Regarding Qu Biologics
Sign Up For FreeTo access detailed company insights
Qu Biologics is at the forefront of developing Site Specific Immunomodulators (SSIs), a novel immunotherapy platform aimed at restoring normal immune function to combat cancer, chronic inflammatory diseases, and metabolic disorders. Their innovative approach leverages the body's natural immune response, targeting specific organs to address immune d... Read More
